Levangie Daniel J
- SEC CIK
- 0001187406
No open-market purchases or sales filed in the past year.
Current role at each company
- EXAS Exact Sciences CorpDirectoras of Jun 16, 2025
- RENXF Renalytix plcDirectoras of Nov 22, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Levangie Daniel J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EXAS Exact Sciences Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 (view filing) | Mar 1 | 3 days | Levangie Daniel JDirector | SSale | −5.00K | $57.50 | −$287.5K | −17.9%23.0K after | 10b5-1 |